Medifast, Inc. Announces $100M Accelerated Share Repurchase Program
prnewswire.com
news
2022-06-01 12:00:00

Investment demonstrates confidence in long-term growth model, aligns interests with stockholders
BALTIMORE, June 1, 2022 /PRNewswire/ -- Medifast, Inc (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today it has entered into an accelerated share repurchase agreement ("ASR") with JPMorgan Chase, National Association ("JPM"), to repurchase an aggregate of $100 million of the company's common stock. This equates to approximately 600,000 shares, at the closing price on May 31, 2022, and represents approximately 5% of the company's fully diluted outstanding stock.
